Company Email Format Management

Imvax, Inc.

Biotechnology Research Philadelphia, Pennsylvania, United States 25 employees

Employees: 25
Contacts: 2
Emails: 2
Phones: 1

imvax.com LinkedIn Crunchbase

Imvax, Inc. Overview

Headquarters: Philadelphia, Pennsylvania, United States
Phone Number: Available in AeroLeads
Website: imvax.com
Industry: Biotechnology Research
Employees: 25
Founded: 2015
Funding: 29.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Immunotherapy Biotechnology Autologous vaccines Biopharmaceuticals Glioblastoma Multiforme Clinical Trials Research

About Imvax, Inc.

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies. Imvax’s combination therapy uniquely captures the complete antigenic signature of a patient’s own tumor and converts it into a highly stimulatory ‘training program’ for the patient’s immune system. The comprehensive nature of this training is intended to result in both innate and adaptive immune stimulation to optimize long-term anti-tumor effects. The company’s lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer, with additional programs in other types of solid tumors.

Imvax, Inc. Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Imvax, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Thomas Pfisterer	Director Direct Investments (Cio-di) @		View
John Limongelli	Chief Legal Officer at Imvax, Inc.	Greater Philadelphia, United States	View
Josh Muntner		New York, United States	Email
Wendy F. Dicicco	Board Member, Financial, Executive	Greater Philadelphia, United States	Email Phone